多潘立酮与出生缺陷：希望这是最后一章。（注：你提供的原文中“Bendectin”一般指的是多潘立酮，不过从医学专业角度看，多潘立酮与出生缺陷并无关联，这里可能存在信息误差，正常医学文献中关于多潘立酮的内容不会提及与出生缺陷的关系。如果“Bendectin”另有正确指代，请根据实际情况调整译文。） - Suppr

Suppr

超能文献

Bendectin and birth defects: hopefully, the final chapter.

作者信息

Brent Robert

机构信息

Jefferson Medical College, Philadelphia, Pennsylvania, USA.

出版信息

Birth Defects Res A Clin Mol Teratol. 2003 Feb;67(2):79-87. doi: 10.1002/bdra.10021.

DOI:10.1002/bdra.10021

PMID:12769503

Abstract

摘要

相似文献

Bendectin and birth defects: hopefully, the final chapter.

Birth Defects Res A Clin Mol Teratol. 2003 Feb;67(2):79-87. doi: 10.1002/bdra.10021.

Bendectin and birth defects. II: Ecological analyses.

Birth Defects Res A Clin Mol Teratol. 2003 Feb;67(2):88-97. doi: 10.1002/bdra.10034.

Return of the morning sickness pill. Could Bendectin be coming back to market?

AWHONN Lifelines. 2001 Feb-Mar;5(1):22-3.

Safety of drug therapy for nausea and vomiting of pregnancy.

J Fam Pract. 1980 Nov;11(6):969-70.

The Bendectin debate.

Can Med Assoc J. 1980 Nov 8;123(9):922-8.

The innocent bystander. Doxylamine/dicyclomine/pyridoxine and congenital limb defects.

Med J Aust. 1984 Apr 28;140(9):525-7.

Safety and efficacy of antiemetics used to treat nausea and vomiting in pregnancy.

Clin Pharm. 1986 Aug;5(8):660-8.

Bendectin and birth defects: I. A meta-analysis of the epidemiologic studies.

Teratology. 1994 Jul;50(1):27-37. doi: 10.1002/tera.1420500105.

Critical appraisal of drug therapy for nausea and vomiting of pregnancy: II. Efficacy and safety of diclectin (doxylamine-B6).

Can J Clin Pharmacol. 2000 Autumn;7(3):138-43.

Indications for bendectin narrowed.

FDA Drug Bull. 1981 Mar;11(1):1-3.

引用本文的文献

Management of Bipolar Disorder in Pregnancy and Postpartum: A Clinicians' Guide.

CNS Drugs. 2025 Jul 1. doi: 10.1007/s40263-025-01202-7.

Nausea and Vomiting of Pregnancy and its Management with the Dual-Release Formulation of Doxylamine and Pyridoxine.

Geburtshilfe Frauenheilkd. 2024 Feb 8;84(2):144-152. doi: 10.1055/a-2225-5883. eCollection 2024 Feb.

Perception of drug teratogenicity among general practitioners and specialists in obstetrics/gynecology: a regional and national questionnaire-based survey.

BMC Pregnancy Childbirth. 2016 Aug 17;16:226. doi: 10.1186/s12884-016-1025-6.

Antihistamines and birth defects: a systematic review of the literature.

Expert Opin Drug Saf. 2014 Dec;13(12):1667-98. doi: 10.1517/14740338.2014.970164. Epub 2014 Oct 11.

The delayed-release combination of doxylamine and pyridoxine (Diclegis®/Diclectin ®) for the treatment of nausea and vomiting of pregnancy.

Paediatr Drugs. 2014 Jun;16(3):199-211. doi: 10.1007/s40272-014-0065-5.

Evaluation of the reproductive and developmental risks of caffeine.

Birth Defects Res B Dev Reprod Toxicol. 2011 Apr;92(2):152-87. doi: 10.1002/bdrb.20288. Epub 2011 Mar 2.

Use of antihistamine medications during early pregnancy and isolated major malformations.

Birth Defects Res A Clin Mol Teratol. 2009 Feb;85(2):137-50. doi: 10.1002/bdra.20513.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验